Failure to Notify Provider and Monitor Resident Leads to Death
Summary
The facility failed to ensure that a resident received treatment and care in accordance with professional standards of practice. Specifically, the facility did not notify the provider about the resident's abnormal lab values, including high potassium levels, and potential drug-to-drug interactions. The resident, who had chronic kidney disease and was on medications that could cause hyperkalemia, was not properly monitored for potassium levels. Additionally, the facility did not notify the provider about the resident's symptoms of nausea and vomiting, which are indicative of hyperkalemia. The resident's medical records revealed that the resident had elevated potassium, high blood urea nitrogen (BUN), high creatinine, and low glomerular filtration rate (GFR). Despite these abnormal lab results, the staff did not contact the provider to notify them. The resident was also prescribed Bactrim, which has a known interaction with Spironolactone, a medication the resident was already taking. The electronic medical record system triggered alerts for these drug interactions, but the staff did not notify the provider or document any communication regarding these alerts. The resident experienced nausea and vomiting, symptoms that could be related to elevated potassium levels, but the staff did not notify the provider. The resident was given Zofran for nausea, which also had potential drug interactions with other medications the resident was taking. The staff failed to document vital signs and did not notify the provider about the resident's condition. Ultimately, the resident was found unresponsive and was pronounced deceased. The facility's failure to notify the provider about abnormal lab results, drug interactions, and the resident's symptoms likely contributed to the resident's death.
Removal Plan
- Facility will review the last 30 days of labs for all current residents. If abnormal lab is discovered, facility will check to see if MD/provider was notified. If not, we will notify MD/Provider and follow any orders given. An identification audit will be completed by the DON/designee. The identification audit will be reported to MD/provider for further interventions based on findings. The DON/designee will communicate orders given by MD/provider for implementation.
- Facility will look at current resident charts for current drug to drug interactions on spironolactone and residents with chronic kidney disease. The DON/designee will check to see if MD/provider was notified. If not, MD/provider will be notified and follow any orders given. An identification audit will be completed by the DON/designee. The identification audit will be reported to MD/provider for further interventions based on findings. The DON/designee will communicate orders given by MD/provider for implementation.
- Facility will educate current nursing staff regarding the process for reviewing labs which is: When new lab results are returned to the center, the nurse will review the lab results to determine if any abnormal lab results are present. The nurse will then notify the MD/provider of the abnormal lab result, follow orders given and document the notification in the medical record.
- Education also to include what to do for drug-to-drug interaction notification in PCC. When the nurse is entering new resident orders into PCC and a notification comes up for a drug-to-drug interaction the nurse is to notify the MD/provider of the interaction, follow orders given and document the notification in PCC.
- DON/designee will complete the education for staff on shift today. Staff not present will receive education before start of their shift.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.